120 related articles for article (PubMed ID: 3142093)
21. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
Philips M; Juul AG; Thorsen S
Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
[TBL] [Abstract][Full Text] [Related]
22. Plasminogen activators and their inhibitors in leukemic cell homogenates.
Wada H; Kumeda Y; Ogasawara Z; Ohiwa M; Kaneko T; Tamaki S; Ohno T; Kageyama S; Kobayashi T; Deguchi K
Am J Hematol; 1993 Feb; 42(2):166-70. PubMed ID: 8438877
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen activator activity in differentiating leukemia cells.
Kidron M; Nachshon I; Mayer M; Fibach E
FEBS Lett; 1984 Nov; 177(1):66-70. PubMed ID: 6238843
[TBL] [Abstract][Full Text] [Related]
24. Human hepatoma cell line plasminogen activator.
Levin EG; Fair DS; Loskutoff DJ
J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
[TBL] [Abstract][Full Text] [Related]
25. Human synovial fibroblasts produce urokinase-type plasminogen activator.
Medcalf RL; Hamilton JA
Arthritis Rheum; 1986 Nov; 29(11):1397-401. PubMed ID: 3096341
[TBL] [Abstract][Full Text] [Related]
26. Hormonal and immunological characterization of the cell-associated plasminogen activators produced by cultured rat granulosa cells.
Knecht M
Endocrinology; 1987 May; 120(5):2174-9. PubMed ID: 3032577
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors.
Niiya K; Nsimba M; Hayashi T; Sakuragawa N
Thromb Res; 1992 Feb; 65(3):311-21. PubMed ID: 1631798
[TBL] [Abstract][Full Text] [Related]
28. Production of proteases type plasminogen activator and their inhibitor in cornea.
Mirshahi M; Mirshahi S; Soria C; Soria J; Thomaidis A; Pouliquen Y; Faure JP
Biochem Biophys Res Commun; 1989 May; 160(3):1021-5. PubMed ID: 2499321
[TBL] [Abstract][Full Text] [Related]
29. Role of plasminogen activator in pemphigus vulgaris.
Wilkinson JE; Smith CA; Suter MM; Falchek W; Lewis RM
Am J Pathol; 1989 Mar; 134(3):561-9. PubMed ID: 2466403
[TBL] [Abstract][Full Text] [Related]
30. Secretion of plasminogen activator inhibitor by cultured human epidermal cells.
Hashimoto K; Nishioka K; Katayama I; Yoshikawa K
Br J Dermatol; 1986 Aug; 115(2):133-8. PubMed ID: 3091060
[TBL] [Abstract][Full Text] [Related]
31. Cells of the human myelomonocytic line RC-2A synthesize tissue factor-like procoagulant and urokinase-type plasminogen activator.
Karhumäki E; Saravo L; Helin H
J Leukoc Biol; 1987 Jul; 42(1):36-42. PubMed ID: 3298513
[TBL] [Abstract][Full Text] [Related]
32. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
[TBL] [Abstract][Full Text] [Related]
33. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
Schatz F; Aigner S; Papp C; Toth-Pal E; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2504-10. PubMed ID: 7629251
[TBL] [Abstract][Full Text] [Related]
34. Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells.
Meissauer A; Kramer MD; Hofmann M; Erkell LJ; Jacob E; Schirrmacher V; Brunner G
Exp Cell Res; 1991 Feb; 192(2):453-9. PubMed ID: 1899072
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a plasminogen activator and its inhibitor in human mesangial cells.
Lacave R; Rondeau E; Ochi S; Delarue F; Schleuning WD; Sraer JD
Kidney Int; 1989 Mar; 35(3):806-11. PubMed ID: 2496257
[TBL] [Abstract][Full Text] [Related]
36. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
37. Human articular cartilage contains an inhibitor of plasminogen activator.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
[TBL] [Abstract][Full Text] [Related]
38. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
Michel JB; Quertermous T
J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
[TBL] [Abstract][Full Text] [Related]
39. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
[TBL] [Abstract][Full Text] [Related]
40. Differences between the F10, BL6 and F1 sublines of the B16 melanoma in the enhancement of plasminogen activator and plasminogen activator inhibitor secretion by phorbol myristate acetate.
Hart DA; Smith R
Cancer Lett; 1987 Apr; 35(1):27-38. PubMed ID: 3105864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
